KATRINA CAMPION: Open Payments
NPI 1871265538 · HILLSBOROUGH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,261 in 32 payments from 10 companies in 2025. Trend: 2023 $559 · 2024 $978 · 2025 $1,261
Food & beverage: $1,252Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $291 |
| Janssen Biotech, Inc. | 3 | $287 |
| Madrigal Pharmaceuticals | 2 | $187 |
| Phathom Pharmaceuticals, Inc. | 1 | $124 |
| Novo Nordisk Inc | 1 | $118 |
| Janssen Scientific Affairs, LLC | 1 | $116 |
| GENZYME CORPORATION | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Ardelyx, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, VOQUEZNA, Wegovy, SKYRIZI, DUPIXENT, ENTYVIO.
Industry payments across NJ — which companies pay providers there.
